Overview
PDAB’s mission is to monitor and mitigate unsupported price increases of prescription drugs for Washingtonians.
PDAB is composed of three bodies:
A board appointed by the Governor, with expertise in health care economics or clinical medicine
A policy team within HCA tasked with advising and supporting the Governor’s board
Advisory groups composed of relevant stakeholders from across Washington, including patients, patient advocates, and experts
PDAB was established following passage of SB5532 by the Washington State Legislature in 2022.
Mission
PDAB is a five-member board tasked with the following duties:
Identify drugs that may be subject to an affordability review
Conduct affordability reviews on selected eligible drugs
Determine whether a prescription drug is unaffordable for Washington consumers
If a drug is found to be unaffordable, the Board may set an upper payment limit.
Meeting details
PDAB meetings will be held every other month and are open to the public.
Stakeholders will be allowed three minutes for comments.
Meetings are sponsored by the Health Care Authority and meet requirements of the Americans with Disabilities Act. Please call our ADA Coordinator at 1-855-682-0787 to make a request for special accommodations. TRS users may call this number through the Washington Relay Service by dialing 711.
Written testimony
If you would like to give testimony but cannot attend a meeting, email a one-page maximum testimony to HCA PDAB at least one week before the meeting.
Meetings held by webinar
If you would like to speak on any topic listed on the agenda, email HCA PDAB by the Monday before the meeting date with:
Your name,
The organization you represent, and
The topic name on the agenda.
The committee chair will call these names after the topic is presented. You will be unmuted and have three minutes to speak.
If you do not sign up ahead of time but would like to speak at the meeting, the committee chair will ask if there are any other stakeholders. Raise your hand and you will be unmuted when your name is called.
Meetings held at HCA
Stakeholder sign up sheets for testimony or comment will be available in the lobby.